The histamine H3 receptor: from discovery to clinical trials with pitolisant

Decreased CSF Histamine in Narcolepsy With and Without Low CSF Hypocretin-1 in Comparison to Healthy Controls

(2017) Seiji Nishino et al.   SLEEP

Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization

(2010) Mikaël Croyal et al.   ANALYTICAL BIOCHEMISTRY

Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases

(2010) Rita Raddatz et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

S.19.05 Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease

(2009) I. Arnulf   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain

(2009) Nora D. Volkow et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Refined Docking as a Valuable Tool for Lead Optimization: Application to Histamine H3Receptor Antagonists

(2008) Nicolas Levoin et al.   ARCHIV DER PHARMAZIE

Histamine H3 Receptor Antagonists Go to Clinics

(2008) Kerstin Sander et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Histamine H3 Antagonists as Wake-Promoting and Pro-Cognitive Agents

(2008) Emily Stocking et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Histamine in the Nervous System

(2008) Helmut L. Haas et al.   PHYSIOLOGICAL REVIEWS

An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy: Studies in orexin−/− mice and patients

(2007) Jian-Sheng Lin et al.   NEUROBIOLOGY OF DISEASE